Hyderabad-based Vivimed Labs Limited, reported a two-fold increase in net profit to Rs 25.54 crore for the quarter ended September 30, 2012, as compared to Rs 12.42 crore in the corresponding quarter last year, registering a 105.64 per cent growth.
Net income grew 114.13 per cent during the quarter to Rs 275.82 crore from Rs 128.81 crore in the same period a year ago, according to a company release.
The total expenditure of the company has increased to Rs 236 crore for the quarter from Rs 226.57 crore in the corresponding quarter last year, registering a 4.16 per cent growth.
The company's scrip is currently trading at Rs 352, up 0.67 per cent over the previous close of Rs 349.65.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app